Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Diabetes may lower the risk of prostate cancer.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

AGA affects many, progresses differently, and early treatment is crucial.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Urban living may increase prostate cancer risk, while early sexual activity might reduce it.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Steroid 5α-reductase evolved from protists and diversified in eukaryotes, with specific roles in mammals and plants.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Physical activity, height, and smoking affect prostate cancer risk.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Edible seeds from the Cucurbitaceae family like pumpkin and watermelon seeds are nutritious and may have health benefits, but eating too much can cause side effects.

Men with a family history of hair loss are more likely to experience it themselves, especially if both parents have hair loss.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

CEC levels may be a useful marker for predicting prostate cancer progression.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.